Table 3. Global assessment of inflammation by visit (intent-to-treat population).

Visit	Assessment score, n (%)	Difluprednate 0.05% (n=39)	Prednisolone acetate 1% (n=40)
Day 1	Total	39	40
	Clear	12 (30.8)	7 (17.5)
	Improving satisfactorily	27 (69.2)	33 (82.5)
	Not improving or worsening	0 (0.0)	0 (0.0)
Day 8	Total	39	40
	Clear	19 (48.7)	10 (25.0)
	Improving satisfactorily	19 (48.7)	28 (70.0)
	Not improving or worsening	1 (2.6)	2 (5.0)
Day 15	Total	39	40
	Clear	22 (56.4)	20 (50.0)
	Improving satisfactorily	17 (43.6)	20 (50.0)
	Not improving or worsening	0 (0.0)	0 (0.0)
Day 29	Total	39	40
	Clear	31 (79.5)	29 (72.5)
	Improving satisfactorily	8 (20.5)	10 (25.0)
	Not improving or worsening	0 (0.0)	1 (2.5)
1 Week after last dose	Total	39	40
	Clear	35 (89.7)	36 (90.0)
	Improving satisfactorily	3 (7.7)	3 (7.5)
	Not improving or worsening	1 (2.6)	1 (2.5)
3 Months after last dose	Total	39	40
	Clear	36 (92.3)	37 (92.5)
	Improving satisfactorily	2 (5.1)	3 (7.5)
	Not improving or worsening	1 (2.6)	0 (0.0)